PFBT
ZVRA icon

Parkside Financial Bank & Trust’s Zevra Therapeutics ZVRA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$861 Hold
60
– – ﹤0.01% 2447
2026
Q1 		$560 Hold
60
– – ﹤0.01% 2549
2025
Q4 		$538 Hold
60
– – ﹤0.01% 2559
2025
Q3 		$571 Hold
60
– – ﹤0.01% 2509
2025
Q2 		$529 Buy
+60
New +$487 ﹤0.01% 2517

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parkside Financial Bank & Trust's ZVRA Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 60 shares worth $861. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Parkside Financial Bank & Trust first reported a position in ZVRA in Q2 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Parkside Financial Bank & Trust held 60 shares of Zevra Therapeutics worth $861 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2447 holding.
  • Parkside Financial Bank & Trust first reported a position in Zevra Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.